In this study, we used oligonucleotide microarray analysis to determine which cellular genes are regulated by the human papillomavirus type 16 (HPV-16) E6 oncoprotein. We found that E6 causes the downregulation of a large number of cellular genes involved in keratinocyte differentiation, including genes such as small proline-rich proteins, transglutaminase, involucrin, elafin, and cytokeratins, which are normally involved in the production of the cornified cell envelope. In contrast, E6 upregulates several genes, such as vimentin, that are usually expressed in mesenchymal lineages. E6 also modulates levels of genes involved in inflammation, including Cox-1 and Nag-1. By using E6 mutants that differentially target p53 for degradation, we determined that E6 regulates cellular genes by both p53-dependent and independent mechanisms. The microarray data also indicate that HPV-16 E6 modulates certain effects of HPV-16 E7 on cellular gene expression. The identification of E6-regulated genes in this analysis provides a basis for further studies on their role in HPV infection and cellular transformation.
Introduction
Human papillomaviruses (HPVs) are small, doublestranded DNA viruses that infect epithelial tissues and induce hyperproliferative lesions (Howley, 1995) . While HPVs infect proliferating basal cells, viral production is associated with terminally differentiated layers of the epithelium. Thus, cellular differentiation and virus production are tightly linked. More than 85 distinct types of HPV have been identified and categorized into different risk groups (zur Hausen, 2000) . Members of the "low-risk" group induce common warts, members of the "intermediate-risk" group induce anogenital warts, and members of the "highrisk" group are associated with anogenital tract lesions that can progress to malignancy (zur Hausen, 1991) . High-risk HPV nucleic acids are detected in 90% of cervical carcinomas and HPV-16 is the predominate member of this group (Howley, 1991) .
E6 and E7 are the major transforming proteins of highrisk HPV types and are known to alter cellular differentiation (Alfandari et al., 1999; Sherman and Schlegel, 1996) , reactivate host DNA synthesis (Cheng et al., 1995) , and stimulate cell-cycle progression (Woodworth et al., 1992) . Expression of E6 and E7 has also been shown to downregulate expression of genes involved in immune responses such as interferon-inducible genes Laimins, 2000, 2001; Nees et al., 2001) . E6 and E7 are thought to perturb cellular gene expression by interfering with the functions of cellular regulatory proteins. HPV E7 is known to bind hypophosphorylated retinoblastoma protein (pRb) Munger et al., 1989) , causing increased levels of active E2F transcription factors. This results in increased expression of genes involved in cell-cycle progression and DNA synthesis. HPV-16 E6 binds a number of cellular proteins including the E6-associated protein (E6AP), a protein-ligase of the ubiquitin proteolysis pathway (Rapp and Chen, 1998) . E6 complexed with E6AP targets the p53 tumor suppressor protein for proteasome degradation (Scheffner et al., 1990) . The p53 protein is a central tran-scription factor important in the regulation of cellular responses to stress and DNA damage, and loss of p53 leads to genetic instability and progression toward malignancy (Vousden and Lu, 2002) . One key downstream effector of p53 is p21 Waf/Cip (hereafter referred to as p21), a cdk/cyclin inhibitor whose upregulation by p53 leads to cell-cycle arrest (El-Deiry et al., 1993) . Interestingly, p21 has been linked to differentiation of keratinocytes (Harvat et al., 1998; Missero et al., 1996) . In addition to its role in p53 degradation, HPV-16 E6 has been shown to bind to numerous other cellular proteins including several transcription factors (Mantovani and Banks, 2001) . It has been shown that HPV-16 E6 has several p53-independent functions that are likely to play a role in the immortalization and the development of malignancy. For example, overexpression of HPV-16 E6 by retroviral-mediated transduction has been shown to activate telomerase by a mechanism that does not rely on p53 degradation (Klingelhutz et al., 1996) . While both E6 and E7 are required for HPV-mediated cellular immortalization, E6 is the primary activator of telomerase and is known to increase transcription of the catalytic subunit of telomerase (hTERT) (Gewin and Galloway, 2001; Klingelhutz et al., 1996; Oh et al., 2001; Veldman et al., 2001) .
In the present study, we used oligonucleotide array analysis of mRNA levels from cells coexpressing HPV-16 E7 with variants of HPV-16 E6 with the aim of identifying genes regulated by E6 that may play a role in cellular transformation and/or the viral life cycle. Our analysis showed that a large number of the genes downregulated by E6 are involved in keratinocyte differentiation and the formation of the cornified barrier. We also identified a number of other genes that were regulated by E6 in both p53dependent and p53-independent manners. The identification of cellular genes regulated by E6 should be useful in understanding the role of E6 in infection and malignant progression of HPV-associated lesions.
Results

Establishment and characterization of cells for microarray analysis
A goal of this study was to identify cellular genes regulated by expression of HPV-16 E6 that may play a role in the HPV life cycle or in cellular transformation. To generate a sufficient number of cells for microarray analysis and subsequent validation, we decided to first extend cellular lifespan by expression of HPV-16 E7. HPV-16 E7 expressing keratinocytes were generated by infecting normal primary cells with an LXSH retrovirus that expressed E7 and conferred hygromycin resistance. After selection in hygromycin, cells were infected with an LXSN retroviral construct that expressed wild-type HPV-16 E6 and conferred G418 resistance. Because we wanted to determine if regu-lation of genes by E6 was dependent on p53 degradation or associated with telomerase activation, we also infected E7 keratinocytes with LXSN retroviruses that expressed HPV-16 E6 variants, ⌬118 -122 and 8S9A10T, that have been shown to be defective in telomerase activation and targeting of p53 for degradation, respectively. Doubly infected cells were selected with G418. Western analysis using a p53-specific antibody demonstrated that keratinocytes that coexpressed E7 with wild-type E6 had degraded p53 as compared to E7 expressing cells infected with vector alone (Fig. 1 ). Cells coexpressing E7 with the E6 mutants, E6 ⌬118 -122, or E6 8S9A10T exhibited partial and no degradation of p53, respectively ( Fig. 1 ). An ELISA-based telomeric repeat amplification protocol (TRAP) analysis showed the cells expressing wild-type E6 or the 8S9A10T mutant had active telomerase, whereas cells expressing vector alone or the ⌬118 -122 mutant did not. These results are similar to those reported previously (Foster et al., 1994; Klingelhutz et al., 1996) . The ⌬118 -122 E6 mutant has been shown to have a decreased ability to target p53 for degradation and this is more apparent in the context of E7 expression. Reverse-transcriptase polymerase chain reac- tion (RT-PCR) analysis for hTERT expression demonstrated that hTERT was upregulated in association with telomerase activity in cells expressing the wild-type E6 and 8S9A10T E6 mutant. Thus, the generated cell lines exhibited the expected phenotypes and were used for subsequent analyses.
Oligonucleotide array analysis of mRNA levels in cells expressing To identify genes that are up-or downregulated by HPV-16 E6, we used Affymetrix gene arrays. Steady-state mRNA levels from four cells types (i.e., HFKs expressing E7 and E6 wild-type, E7 and E6 ⌬118 -122, E7 and E6 8S9A10T, and E7 alone) were analyzed with Affymetrix oligonucleotide arrays (HuFL) that contained probes to 5600 different human genes. Raw data were analyzed with the Affymetrix GENECHIP software package. The oligonucleotide array experiments were performed twice with independently derived cell lines from different keratinocyte donors. We first sorted the data for genes that were up-or downregulated by coexpression of E7 and wild-type E6 as compared to expression of E7 alone. Our sort criteria selected genes that the Affymetrix GENECHIP software identified as Increased or Decreased and had a more than twofold change in mRNA levels. This sort indicated that wildtype E6 caused up-or downregulation of at least 54 genes by two-or more fold. These included genes that were involved in cell structure and differentiation, cell-cycle and DNA damage response, angiogenesis, inflammation and immune response, metabolism, and signal transduction (Table  1) . Because p53 upregulates expression of the cdk/cyclin inhibitor p21, we anticipated that cells expressing wild-type E6 and concomitant degradation of p53 would have lower levels of p21. As expected, p21 transcript was downregulated by fourfold in cells that expressed wild-type E6 and E7 together as compared to E7 alone but not in cells that expressed the E6 mutants that did not target p53 for degradation (Table 1, line 27). This finding was validated by both Northern and Western analyses (Fig. 2) .
Expression of E6 downregulated a large number of genes involved in keratinocyte differentiation (Table 1 , lines 1 to 20), including several genes such as small proline-rich protein genes, elafin, stratum corneum chymotryptic enzyme, involucrin, and keratinocyte transglutaminase, that play a role in the formation of the cornified envelope (Kalinin et al., 2002) . Most of these genes were downregulated regardless of p53 status. The downregulation of two of these genes, SPRR1A and chondroitin sulfate proteoglycan versican (CSPV), was validated by Northern and RT-PCR analyses (Figs. 3 and 4).
Interestingly, E6 upregulated a number of genes that are normally expressed in mesenchymal lineages. For example, tenascin-C, neurofilament heavy chain, vimentin ( 3 and 5a ). In the case of MEST, both the microarray and the Northern analyses indicated that MEST transcripts were upregulated by wild-type E6 and 8S9A10T E6 but not by ⌬118 -122 E6, indicating that upregulation of MEST was independent of p53 degradation (Fig. 3) . Similarly, the microarray analysis indicated that wild-type E6 and 8S9A10T E6, but not ⌬118 -122 E6, upregulated vimentin transcript levels (Table 1 , line 26). Northern analysis for vimentin expression, however, suggested that the ⌬118 -122 E6 mutant also upregulated vimentin but to a lesser extent than was observed for wild-type E6 or 8S9A10T E6 (Fig. 5a ). The reason for the discrepancy between the microarray and Northern analyses is unknown. The results from Western analysis for vimentin were more similar to the microarray results ( Fig. 5b ).
As has been shown previously, E6 also downregulated several genes involved in immune response (Table 1 , lines 33-38) Laimins, 2000, 2001; Nees et al., 2001) . Wild-type E6 downregulated a gene, Nag-1, that is a member of the TGF-␤ superfamily and is known to be involved in an anti-inflammatory response (Table 1, line 31), but upregulated eight-fold the inflammation associated gene, cox-1, which is involved in prostaglandin synthesis (Table  1 , line 32) (Baek et al., 2002) . In the case of cox-1, the microarray data indicated that the E6 mutants did not alter expression. However, RT-PCR analysis demonstrated that both the wild-type and the mutants upregulated expression ( Fig. 4) , thus signifying the necessity of validating the microarray results by performing an independent assay to examine gene expression. The microarray analysis did not indicate downregulation of Stat1, as has been reported previously (Chang and Laimins, 2000) . E6 or E7 regulation of Stat1 protein levels or phosphorylation was also not observed by Western analysis (Fig. 5b ).
Conspicuously absent from the microarray data is hTERT, the reverse transcriptase component of telomerase, that was included on the microarray and was shown to be upregulated by wild-type E6 and 8S9A10T by RT-PCR analysis. The reason for this discrepancy is unknown, but because hTERT is expressed at low levels even in telomerase-positive cells (Meyerson et al., 1997; Nakamura et al., 1997) , the microarray analysis was probably not sensitive enough to detect the transcript. This latter observation indicates that microarray analysis may not be an ideal method to examine changes in transcripts that are expressed at low levels.
Differential regulation of genes by E6 and E7
In general, E6 and E7 are thought to be expressed simultaneously in HPV-infected cells. Therefore, we decided to compare array data from cells that expressed E6 and E7 together to array data from normal keratinocytes that expressed vector (LXSN) alone. The microarray data from cells that expressed E7 alone were compared to data from 
Nonspecific crossreacting ( cells that expressed vector alone to determine how expression of E7 alone affected transcript levels. Again, the array experiments were performed twice with independently derived LXSN-, E7-, or E6/E7-expressing cells from different HFK cell strains.
In most cases, the genes that were up-or downregulated by E6/E7 as compared to E7 alone were also found to be upor downregulated in a similar fashion by E6/E7 as compared to vector alone (Table 1) . For many genes, a more dramatic effect was observed when comparing E6/E7 cells to vector alone cells as opposed to comparison of E6/E7 cells to E7 alone cells. For example, expression of SPRRIA was reduced 3.0-fold in E6/E7-expressing cells as compared to E7-expressing cells but was reduced 8.5-fold as compared to cells that contained vector alone (Table 1, line 2). For several genes, the data indicated that E7 caused a change in transcript levels in one direction, whereas concomitant expression of E6 caused a change in transcript levels in the opposite direction. A good example to illustrate this point is the gene vimentin (Table 1, line 26). In this particular case, E7 downregulated expression by 3.9-fold as compared to vector only keratinocytes. Concomitant expression of E6 upregulated expression by 4.0-fold, with a net effect of b Genes are listed that were altered by two or more fold and called "increased" or "decreased" by Affymetrix GeneChip Software in two independent comparisons of E6/E7 vs E7 expressing cells. The number shown represents the average fold change of the two comparisons. Negative values represent a decrease whereas positive values represent an increase. Fig. 2. (a) Northern blot to determine levels of p21 Cip/Waf transcripts. A 36B4 probe was used for a control. Lanes are the same as in Fig. 1. (b) Western blot for p21 Cip/Waf protein expression. An antibody for ␤-actin was used as a control. Lanes are the same as in Fig. 1.   Fig. 3 . Northern blot to determine levels of MEST and SPRRIA transcripts. A 36B4 probe was used as a control. Lanes are the same as in Fig. 1. 1.1-fold upregulation when comparing E6/E7 keratinocytes to vector-only keratinocytes. A Western analysis using a vimentin antibody confirmed these observations and also indicated that the effect on vimentin expression was independent of p53 degradation (Fig. 5b) . These results suggest that the regulation of some cellular genes by E7 is moderated by expression of E6.
Discussion
In this study we have identified genes that are regulated by expression of HPV-16 E6 in human keratinocytes. We found by microarray analysis that at least 54 genes were upor downregulated twofold or more by expression of E6 in the context of E7 expression. Although some alterations in gene expression (e.g., p21) were dependent on p53 degradation, many others were not. This data provide further evidence that HPV-16 E6 exerts many of its effects independently of p53.
One of the initial objectives of this study was to identify genes that might play a role in upregulation of hTERT and telomerase activation by E6. This goal was modified, however, when it was observed that the microarrays were not sensitive enough to detect alterations in hTERT levels in cells that expressed E6. An inference from this result is that changes in cellular genes that affect hTERT expression may also not be picked up by the microarrays. Nevertheless, a number of interesting E6-regulated genes were identified in this analysis.
Many of the genes that were downregulated by E6 are genes that encode proteins involved in keratinocyte differentiation. This downregulation was observed when E6 and E7 were coexpressed, either when compared to expression profiles of cells that contained vector alone or E7 alone. The E6 mutant, 8S9A10T, that did not target p53 for degradation also caused downregulation of many of the same genes, indicating that the mechanism of downregulation by E6 is independent of p53 degradation. The reason that HPV downregulates genes involved in keratinocyte differentiation is not completely clear. It has been demonstrated by others that HPV-16 E6 inhibits serum-and calcium-induced differentiation of human keratinocytes (Sherman and Schlegel, 1996) . Our results identify several of the genes that may be involved in this process. A previous study using microarrays showed evidence that E6 and E7 may affect differentiation through downmodulating the transforming growth factor-␤ (TGF-␤) pathway (Nees et al., 2000) . In our studies, we did not observe downregulation of either TGF-␤ isoforms or TGF-␤ receptors. The reason for this discrep- ancy is unknown but might have to do with the fact that we used serum-free, nondifferentiating media in our experiments. In addition, Nees et al. used cervical keratinocytes and we used foreskin keratinocytes. Nevertheless, both studies indicate that HPV-16 modulates expression of differentiation-associated genes. The life cycle of HPV is closely associated with differentiation and expression of late genes is not thought to occur until cells have begun to differentiate. HPV-16 E6 and E7 delay cellular differentiation and keep cells in a state of DNA synthesis even after they have entered the suprabasal layer of the epidermis. Thus, the downregulation of differentiation genes may augment this process and also play a role in the development of malignancy. On the other hand, many of the genes identified to be downregulated by E6 are normally involved in formation of the cornified envelope. Disruption of the cornified envelope may play some role in release of mature HPV virions during the HPV life cycle (Brown and Bryan, 2000; Lehr et al., 2002) . This hypothesis can only be addressed using a system in which HPV-16 virions can be produced.
Other groups have shown by microarray analysis that HPV-16 and -31 E6 and E7 can downregulate genes involved in immune responses such as the interferon-regulated gene Stat-1 (Chang and Laimins, 2001; Nees et al., 2001) . We did not see significant modulation of Stat-1 by HPV-16 E6/E7 as compared to E7 in our analysis, nor did we see modulation in E6/E7 cells as compared to vector alone. The reason for this is unknown but, again, may have to do with culture conditions. We did observe downregulation of the interferon-inducible gene Staf50 and modulation of several genes involved in inflammation such as Nag-1, Cox-1, and IRAP, suggesting that E6 plays a role in regulation of the immune/inflammatory response.
One interesting finding of this study was that some cellular genes are differentially regulated by E6 and E7. For example, our data suggest that E6 and E7 divergently regulate vimentin: E6 maintained or even slightly increased vimentin levels compared to the vector control, E7 caused vimentin downregulation, and coexpression of E6 and E7 resulted in intermediate vimentin levels. Vimentin, an intermediate filament protein normally expressed in mesenchymal cells, has been shown to be overexpressed in cervical cancers (Gilles et al., 1996) . Interestingly, another gene that was differentially regulated by E6 and E7 in a similar fashion to vimentin is MEST, a gene with homology to the ␣/␤-hydrolase family, which is also normally expressed in mesenchymal lineages (Kaneko-Ishino et al., 1995; Sado et al., 1993) . The differential regulation of vimentin and MEST could not be attributed to p53 status as the 8S9A10T E6 mutant also upregulated expression. Whether differential regulation of vimentin, MEST, or any other genes plays a role in the HPV life cycle or transformation remains to be determined. It is generally believed that HPV-16 E6 and E7 are expressed concomitantly in cells as they are both contained on a single transcript (Howley, 1995) . There is evidence, however, that differential splicing could be involved in modulating levels of E6 and E7 (Pim and Banks, 1999) . Thus, there is a possibility that E6 and E7 are expressed at different ratios during different stages of the viral life cycle. Upregulation of mesenchymal-specific genes might suggest a switch to a more mesenchymal phenotype in cells that express E6. This switch could be important in conversion of cells to a more malignant phenotype. One study, for example, indicated that vimentin is upregulated during the course of HPV-mediated immortalization (Gilles et al., 1994) . It would be interesting to determine if expression of genes such as vimentin are dependent on levels of E6 or E7 expression. This type of study will only become possible when good antibodies for E6 and E7 are developed.
In summary, we have identified a number of cellular genes that are regulated by expression of HPV-16 E6. These genes are involved in such processes as differentiation, cell-cycle control, and immune response. The E6-regulated genes identified in this analysis may play a role in the HPV life cycle and/or in HPV-mediated carcinogenesis.
Materials and methods
Cell culture
Primary cultures of human foreskin keratinocytes (HFKs) were established from foreskin tissue obtained from newborns. Keratinocytes were maintained in Keratinocyte-SFM (Gibco-BRL, Rockville, MD) and cultures were sampled for TRAP, protein, or RNA when approximately 80% confluent. Primary cultures of HFKs were first infected with a retrovirus expressing HPV-16 E7 in a pLXSH vector and then subsequently infected with LXSN-based retroviruses expressing wild-type HPV-16 E6, mutant 8S9A10T E6, or mutant ⌬118 -122 E6 as previously described (Foster et al., 1994) . Identical retroviral infections were performed on two independently derived HFK cells strains. After infection, keratinocytes were selected in 8 g/ml hygromycin (pLXSH-E7) or 50 g/ml neomycin (pLXSN constructs) for 6 -8 days and were subcultured at least twice prior to use in TRAP or extraction of protein or RNA.
Telomeric repeat amplification protocol
Monolayer cultures of HFKs expressing E7 and/or mutant or wild-type E6 were washed with PBS and removed from tissue culture plates through trypsinization. Cells (2 ϫ 10 5 ) were collected and washed with PBS. Cells were collected through centrifugation and cell pellets were stored at Ϫ80°C. Telomerase activity was measured using the Telo TAGGG Telomerase PCR ELISA kit (Roche Diagnostics, Indianapolis, IN).
RNA isolation and purification
For microarray analyses, RNA was extracted from growing monolayer cultures using the RNAqueous-Midi largescale, phenol-free, total RNA isolation kit (Ambion, Inc., Austin, TX). Total RNA was precipitated at Ϫ20°C overnight with 0.1 volume of ammonium acetate and two volumes 100% ethanol, centrifuged at 15,000 rpm, washed with 80% ethanol, dried by evaporation, and resuspended in diethyl pyrocarbonate-treated water. The integrity of RNA was analyzed by electrophoresis and samples were stored at Ϫ80°C. Total RNA for Northern or RT-PCR analyses was extracted by a similar method or by using Tri-Reagent (Molecular Research Center, Inc., Cincinnati, OH) following the manufacturer's protocol.
Oligonucleotide array analysis
Biotinylated single-stranded antisense RNA samples were prepared for hybridization as follows. cDNA was synthesized using the Superscript Double-Stranded cDNA Synthesis kit (Gibco-BRL). First-strand cDNA synthesis reactions were performed using 40 g of total RNA, prepared as above, and oligo(dT) primers containing a T7 RNA polymerase promoter sequence at the 5Ј end [5Ј-GGCCAGTGAATTGTAATAC-GACTCACTATAGGGAGGCGG(T) 24 -3Ј]. Second-strand synthesis was performed using Escherichia coli DNA polymerase I and ligase. The resulting double-stranded cDNA samples were cleaned through phenol:chloroform:isoamylalcohol extraction and ethanol-ammonium acetate precipitation. Samples were resuspended in 13 l diethyl pyrocarbonate treated water. Biotin-labeled cRNA was synthesized from 4 l of the double-stranded cDNA samples by in vitro transcription using the BioArray High Yield RNA Transcript Labeling kit (Enzo Diagnostics, Inc., Farmingdale, NY). Labeled cRNA samples were cleaned using the RNeasy Mini kit (Qiagen, Inc., Valencia, CA) and eluted with 25 l diethyl pyrocarbonate-treated water. Labeled cRNA samples were fragmented to an average size of 100 -200 bases by incubating at 94°C for 35 min in a buffer containing 40 mM Tris-acetate (pH 8.1), 100 mM KOAc, and 30 mM MgOAc.
The array hybridization, washing, and staining procedures were performed by the University of Iowa DNA Facility according to Affymetrix protocols using 12 g samples of labeled, fragmented cRNA on gene chips with probes to 5600 full-length human genes (HuGeneFL Arrays, Affymetrix, Inc., Santa Clara, CA). The DNA arrays were scanned by the University of Iowa DNA Facility using a confocal scanner manufactured for Affymetrix by Molecular Dynamics.
Data collected in each hybridization experiment were processed using the GENECHIP software supplied with the Affymetrix instrumentation system. To minimize false positives, we used cutoff thresholds empirically determined to be conservative. The change in mRNA level for any gene was considered significant if (1) it was considered Increased or Decreased by the Difference Call Decision Matrix algorithm of the GENECHIP software, and (2) it had a fold change of more than twofold as calculated by a Comparison Analysis algorithm of the GENECHIP software.
RT-PCR hTERT
Relative quantitative multiplex RT-PCR was performed using 18S rRNA internal controls as follows. cDNA synthesis reactions were performed using Ambion's RETROscript kit (Ambion). Samples (2 g) of DNase I-treated total RNA were used as the template for single-stranded cDNA synthesis reactions primed with the random decamers included in the RETROscript kit. Multiplex PCR reactions were performed using one-twentieth of each reverse-transcription reaction with primers for both the 18S rRNA internal control and the gene of interest. To avoid saturation or plateau effect, the linear range of amplification efficiency for each gene studied was determined by comparing the amplification products from identical reactions removed from the thermalcycler every other cycle. The number of cycles that yielded an amplification-efficiency in the middle of this linear range was used in subsequent reactions. To ensure accurate quantification, the amplification efficiency of the 18S internal control was modulated using Quantum-RNA 18S Internal Standards Primers and Competimers (Ambion) to give a product quantity similar to that of the gene of interest. RT-PCR reaction products were separated by agarose gel electrophoresis and stained with SYBR Green I nucleic acid gel stain (Roche Molecular Biochemicals). The primers for amplification of hTERT were forward 5Ј-TTCCTGCACTGGCTGATGAGTGT-3Ј and reverse 5Ј-CGCTCGGCCCTCTTTTCTCTG-3Ј with an annealing temperature of 57°C, yielding an amplicon of 329 bp.
Cox-1, CSPV, 36B4
For RT-PCR of Cox-1, chondroitin sulfate proteoglycan versican (CSPV), and the internal control, 36B4, cDNA was synthesized from 1 g of total RNA using the RETROScript kit (Ambion) according to the manufacturer's protocol using random decamers. The following primers and conditions were used for RT-PCR amplification of the indicated genes: Cox-1, forward primer 5Ј-ACCAGGGCATCTGTGTCC-3Ј, reverse primer 5Ј-CCAGCTGATGTAGTCATGTG-3Ј, annealing temperature of 50°C, 30 cycles, 295-bp product; CSPV, forward primer 5Ј-CAAGCATCCTGTCTCACGAA-3Ј, reverse primer 5Ј-ACATGTTCGCCATTTTAGGG-3Ј, annealing temperature of 52°C, 33 cycles, 600-bp product; 36B4, forward primer 5Ј-GGCCAGCTGGAAGTCCAACT-3Ј, reverse primer 5Ј-CCATCAGCACCACAGCCTTC-3Ј, annealing temperature of 54°C, 23 cycles, 150-bp product (Bieche et al., 2000) . PCR was performed using Ambion's SuperTaq.
Northern analysis
Northern probes for vimentin, SPRR1A, and MEST were generated by cloning a 600-bp RT-PCR product into pGEM-T (Promega), releasing the insert by restriction digestion, and isolating the insert by gel extraction using the Qiagen gel extraction kit. The primers used to generate the probes were as follows: vimentin, forward primer 5Ј-GCAAAACACCCTGCAATCTT-3Ј, reverse primer 5Ј-TGGCAATCTCAATGTCAAGG-3Ј; SPRR1A, forward primer 5Ј-ACACAGCCCATTCTGCTCCG-3Ј, reverse primer 5Ј-TGCAAAGGAGCGATTATGATT-3Ј; MEST, forward primer 5Ј-TCAAAGATGGAGGTGTGCTG-3Ј, reverse primer 5Ј-CTCCTGCTGGCTTCTTCCTA-3Ј. The probe for p21 was a 2.1-kb insert released by BamHI digestion of a plasmid kindly provided by Guy Adair (M.D. Anderson). For Northern blotting, 20 g total RNA was separated on a denaturing formaldehyde gel, 1.2% agarose. RNA was transferred to either Zeta Probe (Bio-Rad) or Hybond-XL (Amersham) membranes and hybridization was performed following manufacturers' protocols. Probe DNA was labeled with [ 32 P]dCTP using either HotPrime (Gen-Hunter Corp.) or the MegaPrime (Amersham-Pharmacia) DNA labeling kits according to the manufacturers' protocols. Membranes were hybridized overnight, washed, and exposed to film for autoradiography.
Western blot protein analysis
Western blot analyses of cellular protein levels were performed as previously described (Foster et al., 1994) using 30 g of each protein lysate. Monoclonal antibodies were obtained from the following sources: p53, vimentin, and actin (Santa Cruz Biotechnology, Inc.), Stat1 (Cell Signal Technologies), and p21 (Pharmingen).
